Daré Bioscience, Inc. (DARE)

Daré Bioscience Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	10.33	15.7	10.48	34.67	51.67	4.67
Cash & Short-Term Investments	10.33	15.7	10.48	34.67	51.67	4.67
Cash Growth	184.53%	49.85%	-69.78%	-32.91%	1006.64%	-2.31%
Other Receivables	0.11	0.23	0.95	1.7	1.15	0.46
Receivables	0.11	0.23	0.95	1.7	1.15	0.46
Prepaid Expenses	1.39	2.52	6.12	6.67	2.48	1.85
Total Current Assets	11.82	18.45	17.54	43.04	55.3	6.98
Property, Plant & Equipment	5.72	2.54	1.98	0.52	0.24	0.28
Long-Term Deferred Charges	-	-	-	-	0.14	-
Other Long-Term Assets	1.08	1.11	1.76	0.26	0.13	0.29
Total Assets	18.62	22.1	21.28	43.83	55.81	7.55
Accounts Payable	1.88	1.46	3.39	2.03	2.1	1.02
Accrued Expenses	1.77	3.04	2.89	10.89	3.14	3.36
Short-Term Debt	-	-	-	-	-	0.37
Current Portion of Leases	2.32	0.55	0.47	0.4	0.27	0.35
Current Unearned Revenue	15.12	16.56	13.74	18.3	10.54	1.56
Other Current Liabilities	0.09	-	-	-	-	1
Total Current Liabilities	21.19	21.61	20.48	31.62	16.05	7.66
Long-Term Leases	1.25	0.75	0.94	0.09	-	0.04
Long-Term Unearned Revenue	5.74	5.75	4.91	1	1	1
Total Liabilities	28.18	28.11	26.33	32.71	17.05	8.7
Common Stock	0	0	0	0.01	0.01	0
Additional Paid-In Capital	170.52	169.71	166.55	152.53	149.03	70.37
Retained Earnings	-179.67	-175.29	-171.24	-141.07	-110.13	-71.43
Comprehensive Income & Other	-0.42	-0.43	-0.36	-0.35	-0.15	-0.09
Shareholders' Equity	-9.56	-6.01	-5.05	11.11	38.75	-1.15
Total Liabilities & Equity	18.62	22.1	21.28	43.83	55.81	7.55
Total Debt	3.57	1.3	1.4	0.49	0.27	0.76
Net Cash (Debt)	6.76	14.4	9.07	34.18	51.4	3.91
Net Cash Growth	239.80%	58.68%	-73.46%	-33.51%	1213.79%	-1.68%
Net Cash Per Share	0.79	1.69	1.25	4.85	10.09	1.56
Filing Date Shares Outstanding	8.85	8.85	8.38	7.18	7	3.94
Total Common Shares Outstanding	8.85	8.7	8.33	7.07	7	3.47
Working Capital	-9.37	-3.16	-2.94	11.41	39.24	-0.68
Book Value Per Share	-1.08	-0.69	-0.61	1.57	5.54	-0.33
Tangible Book Value	-9.56	-6.01	-5.05	11.11	38.75	-1.15
Tangible Book Value Per Share	-1.08	-0.69	-0.61	1.57	5.54	-0.33
Machinery	-	0.24	0.16	-	-	-
Construction In Progress	-	1.23	0.6	-	-	-
Leasehold Improvements	-	0.04	0.04	-	-	-

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q